Increased serum levels of advanced glycation end-products and diabetic complications
- 1 August 1998
- journal article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 41 (2), 131-137
- https://doi.org/10.1016/s0168-8227(98)00074-6
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathyKidney International, 1995
- Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease.Proceedings of the National Academy of Sciences, 1994
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Immunochemical detection of advanced glycation end products in lens crystallins from streptozocin-induced diabetic ratDiabetes, 1993
- Hemoglobin-AGE: A Circulating Marker of Advanced GlycosylationScience, 1992
- Immunohistochemical detection of advanced glycosylation end products in diabetic tissues using monoclonal antibody to pyrraline.JCI Insight, 1992
- Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathyKidney International, 1991
- Advanced Glycosylation End Products in Patients with Diabetic NephropathyNew England Journal of Medicine, 1991
- Nonenzymatic Glycosylation, the Maillard Reaction and the Aging ProcessJournal of Gerontology, 1990
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988